皇冠博彩app
热门标签

科学上网电报群:Sanofi ends cancer drug trials

时间:1个月前   阅读:1   评论:1

科学上网电报群www.tg888.vip)是一个Telegram群组分享平台,科学上网电报群内容包括Telegram群组索引、Telegram群组导航、新加坡Telegram群组、Telegram中文群组、Telegram群组(其他)、Telegram 美国 群组、Telegram群组爬虫、电报群 科学上网、小飞机 怎么 加 群、tg群等内容,为广大电报用户提供各种电报群组/电报频道/电报机器人导航服务。

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

PARIS: Sanofi is ending development of a key cancer medicine in a blow to the French drugmaker’s pipeline of experimental therapies.

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

The move leaves Sanofi even more dependent for growth on blockbuster Dupixent, an antibody treatment for ailments ranging from asthma to severe eczema.

The company’s slate of experimental medicines has faced other setbacks, including safety concerns regarding multiple sclerosis treatment tolebrutinib.

,

精彩足球推荐分析www.99cx.vip)是一个开放皇冠体育网址代理APP下载、皇冠体育网址会员APP下载、皇冠体育网址线路APP下载、皇冠体育网址登录APP下载的官方平台。精彩足球推荐分析上足球分析专家数据更新最快。精彩足球推荐分析开放皇冠官方会员注册、皇冠官方代理开户等业务。

,

Sanofi has included both amcenestrant and tolebrutinib as among six products in its pipeline that it prioritised as “potentially transformative” treatments.

Some investors are questioning the company’s growth trajectory after both of those medicines encountered problems.

UBS analysts last week downgraded Sanofi, saying there are few major catalysts coming soon to drive more excitement to the stock. — Bloomberg


转载说明:本文转载自Sunbet。

上一篇:胜负彩(www.99cx.vip):Wilmar International's half-year profit rises 55% on strong China demand

下一篇:Allbet官网(www.aLLbet8.vip):Kerjaya Prospek's 2Q net profit, revenue jump on higher billings

网友评论

  • 2022-08-27 00:07:37

    KUALA LUMPUR: Pertama Digital Bhd has obtained its shareholders' approval to dispose of its entire stake in China-based textile subsidiary, BeTop Group Ltd, to Gifted Investments Limited for RM70mil.简直是艺术品了